Jens Grueger is a highly accomplished and well-respected leader in the healthcare industry with extensive experience in health economics, outcomes research, and market access strategy. He holds a PhD in Mathematical Statistics and Theoretical Medicine from the TU Dortmund University. Grueger has held various senior executive roles in notable companies such as Pfizer, Novartis, and Roche Pharmaceuticals where he was the SVP and head of Global Access. He is currently the President of ISPOR, an international professional society for health economics and outcomes research. Grueger was also an Affiliate Professor at the University of Washington and a former Director and Partner at Boston Consulting Group (BCG).

Throughout his career, Grueger has demonstrated expertise in managing pricing, market access, and reimbursement strategies for various products and therapeutic areas. He has also excelled in leading teams in developing and implementing evidence-based health economic models to demonstrate the value of treatments to various stakeholders, including patients, providers, payers, and policymakers.